4.5 Review

Magic and mystery of microRNA-32

Journal

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 25, Issue 18, Pages 8588-8601

Publisher

WILEY
DOI: 10.1111/jcmm.16861

Keywords

cancer; cardiovascular disorders; metabolic; microRNA

Funding

  1. National Natural Science Foundation of China [81873651]
  2. Major Scientific Research Projects of Hunan health and family planning commission [20201901]
  3. Scientific Research Fund of Education Department of Hunan Province [16B230, 20C1592]

Ask authors/readers for more resources

MiR-32 is a small noncoding RNA molecule that regulates gene expression by base pairing with mRNA, playing important roles in various diseases with both oncogenic and tumor-suppressive effects, as well as crucial roles in metabolic and cardiovascular disorders. New findings suggest its potential as a noninvasive biomarker and targeted therapeutic in multiple diseases.
MicroRNAs (miRNAs) are a group of endogenous, small (similar to 22 nts in length) noncoding RNA molecules that function specifically by base pairing with the mRNA of genes and regulate gene expression at the post-transcriptional level. Alterations in miR-32 expression have been found in numerous diseases and shown to play a vital role in cell proliferation, apoptosis, oncogenesis, invasion, metastasis and drug resistance. MiR-32 has been documented as an oncomiR in the majority of related studies but has been also verified as a tumour suppressor miRNA in conflicting reports. Moreover, it has a crucial role in metabolic and cardiovascular disorders. This review provides an in-depth look into the most recent finding regarding miR-32, which is involved in the expression, regulation and functions in different diseases, especially tumours. Additionally, this review outlines novel findings suggesting that miR-32 may be useful as a noninvasive biomarker and as a targeted therapeutic in several diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET

Yingying Shen, Wei Zhang, Jianghua Liu, Jun He, Renxian Cao, Xiguang Chen, Xiuda Peng, Haifan Xu, Qiang Zhao, Jing Zhong, Wenjun Ding, Xiaoyong Lei, Yuyang Jiang, Xuyu Zu

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Cell Biology

OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway

Zeng Zhaolin, Chen Jiaojiao, Wu Peng, Liu Yami, Zhang Tingting, Tao Jun, Wu Shiyuan, Xiao Jinyan, Wei Dangheng, Jiang Zhisheng, Wang Zuo

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Endocrinology & Metabolism

Serum zinc-2-glycoprotein levels are elevated and correlated with thyroid hormone in newly diagnosed hyperthyroidism

Xin-Hua Xiao, Xiao-Yan Qi, Jiao-Yang Li, Yi-Bing Wang, Ya-Di Wang, Zhe-Zhen Liao, Jing Yang, Li Ran, Ge-Bo Wen, Jiang-Hua Liu

BMC ENDOCRINE DISORDERS (2019)

Article Immunology

MicroRNA-32-5p knockout eliminates lipopolysaccharide-induced depressive-like behavior in mice through inhibition of astrocyte overactivity

Xiaolin Zhong, Wenyu Cao, Heng Zhao, Ling Chen, Jingsong Cao, Lanji Wei, Yifei Tang, Jing Zhong, Xinhua Xiao, Xuyu Zu, Jianghua Liu

BRAIN BEHAVIOR AND IMMUNITY (2020)

Article Immunology

miR32-5p promoted vascular smooth muscle cell calcification by upregulating TNFα in the microenvironment

Jingsong Cao, Ling Chen, Xiaoling Zhong, Yingying Shen, Yan Gao, Qian Chen, Xuyu Zu, Jianghua Liu

BMC IMMUNOLOGY (2020)

Article Cell Biology

FGF21 induces autophagy-mediated cholesterol efflux to inhibit atherogenesis via RACK1 up-regulation

Lin Xiaolong, Guo Dongmin, Mihua Liu, Wang Zuo, Hu Huijun, Tan Qiufen, Hu XueMei, Lin Wensheng, Pan Yuping, Lin Jun, Zeng Zhaolin

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Oncology

FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis

Zhaolin Zeng, Qiuping Zheng, Jiaojiao Chen, Xianhua Tan, Qiang Li, Lingxin Ding, Ren Zhang, Xiaolong Lin

EXPERIMENTAL CELL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Melatonin inhibits vascular endothelial cell pyroptosis by improving mitochondrial function via up-regulation and demethylation of UQCRC1

Junfa Zeng, Jun Tao, Linzhen Xia, Zhaolin Zeng, Jiaojiao Chen, Zuo Wang, Jun Meng, Lushan Liu

Summary: Melatonin prevents endothelial cell pyroptosis by up-regulating TET2 to inhibit the methylation of UQCRC1 and improving mitochondrial function, thereby inhibiting oxidative stress and endothelial cell pyroptosis.

BIOCHEMISTRY AND CELL BIOLOGY (2021)

Article Endocrinology & Metabolism

High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome

Tao Hong, Jiao-Yang Li, Ya-Di Wang, Xiao-Yan Qi, Zhe-Zhen Liao, Poonam Bhadel, Li Ran, Jing Yang, Bin Yan, Jiang-Hua Liu, Xin-Hua Xiao

Summary: The study found that serum asprosin levels were higher in subjects with MetS and showed an increasing trend with the number of metabolic components. Asprosin was positively correlated with BMI, waist circumference, triglycerides, glucose, insulin, and inflammatory markers, and negatively correlated with HDL cholesterol.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2021)

Article Neurosciences

The expression of m6A enzymes in the hippocampus of diabetic cognitive impairment mice and the possible improvement of YTHDF1

Menglin Li, Xiaolin Zhong, Zhibo Zhao, Zhaolin Zeng, Qing Yuan, Xinhua Xiao, Xuyu Zu, Jianghua Liu

Summary: This study investigated the expression of the m6A enzyme in the hippocampus of mice with diabetes-induced cognitive impairment and explored the potential improvement with overexpression of YTHDF1. The results suggest that the m6A enzyme may play a key role in cognitive dysfunction induced by diabetes, and YTHDF1 may be a promising therapeutic target.

BRAIN RESEARCH (2022)

Article Cell Biology

Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop

Yingying Shen, Qingyun Zhu, Maoyu Xiao, Liyang Yin, Wenjie Feng, Jianbo Feng, Jun He, Pei Li, Xiguang Chen, Wenjun Ding, Jing Zhong, Zhaolin Zeng, Zhuoye Xie, Jianghua Liu, Xuyu Zu

Summary: This study found that the small-molecule tyrosine kinase inhibitor DCC-2036 can suppress breast cancer stem cells by inhibiting the AXL and KLF5 proteins. Additionally, DCC-2036 has the potential to increase the effectiveness of chemotherapy for TNBC.

CELL DEATH & DISEASE (2022)

Review Cell Biology

Mitochondrial Stress in Metabolic Inflammation: Modest Benefits and Full Losses

Qing Yuan, Z. L. Zeng, Shiqi Yang, Anqi Li, Xuyu Zu, Jianghua Liu

Summary: Energy intake and metabolic balance are crucial for maintaining health. Overnutrition can cause metabolic inflammation, leading to various metabolic disorders. Mitochondrial dysfunction is closely associated with metabolic inflammation. Excellent organism design can maintain metabolic health even in the presence of mitochondrial dysfunction.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

No Data Available